Filing Details

Accession Number:
0001127602-21-001043
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-06 16:53:20
Reporting Period:
2021-01-04
Accepted Time:
2021-01-06 16:53:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1703647 Frequency Therapeutics Inc. FREQ Pharmaceutical Preparations (2834) 472324450
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1785288 L. David Lucchino C/O Frequency Therapeutics, Inc.
19 Presidential Way, 2Nd Floor
Woburn MA 01801
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-04 3,913 $0.61 327,713 No 4 M Direct
Common Stock Acquisiton 2021-01-04 14,477 $0.61 342,190 No 4 M Direct
Common Stock Disposition 2021-01-04 22,241 $32.89 319,949 No 4 S Direct
Common Stock Disposition 2021-01-04 11,763 $33.81 308,186 No 4 S Direct
Common Stock Disposition 2021-01-04 100 $35.46 308,086 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2021-01-04 3,913 $0.00 3,913 $0.61
Common Stock Stock Option Disposition 2021-01-04 14,477 $0.00 14,477 $0.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-06-28 No 4 M Direct
274,433 2028-05-21 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2020.
  2. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $32.545 to $33.535. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  3. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $33.545 to $34.5. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  4. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $35.45 to $35.59. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  5. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2017, and became fully vested and exercisable on January 1, 2021.
  6. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2018, and will be fully vested and exercisable on January 1, 2022.